Yangzhou, China Clinical Trials

A listing of Yangzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre study assessing the efficacy and safety of durvalumab compared with placebo, as consolidation therapy in patients with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.

lung carcinoma
chemoradiotherapy
durvalumab
Research Site
 (2.0 away) Contact site
  • 284 views
  • 25 Nov, 2020
  • +144 other locations
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

The purpose of this study is to evaluate the efficacy of helicobacter pylori (HP) eradication with bismuth-containing quadruple therapy with vonoprazan versus esomeprazole in all HP-positive participants.

clarithromycin
breath test
bismuth
amoxicillin
omeprazole
Yangzhou First People's Hospital
 (0.0 away) Contact site
  • 0 views
  • 13 Sep, 2020
  • +28 other locations
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of durvalumab + tremelimumab combination therapy + Standard of care (SoC) chemotherapy or durvalumab monotherapy + SoC chemotherapy versus SoC chemotherapy alone as first line treatment in patients with metastatic non small-cell lung cancer …

Research Site
 (2.0 away) Contact site
  • 712 views
  • 05 Nov, 2020
  • +143 other locations
Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Patient With ESCC

This is a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare the efficacy and safety of BGB-A317 versus Placebo with chemoradiotherapy in Patients with Localized Esophageal Squamous Cell Carcinoma.

Northern Jiangsu people's hospital
 (2.0 away) Contact site
  • 1 views
  • 10 Nov, 2019
  • +5 other locations
Vitamin C Thiamine and Hydrocortisone for the Treatment of Septic Shock

The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine and hydrocortisone) is effective in the treatment of septic shock.

thiamine
Northern Jiangsu Province people's hospital
 (0.0 away) Contact site
  • 0 views
  • 26 Oct, 2020
  • 1 location
R CEOP90 Versus R CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL

This clinical trial is designed to compare the efficacy and safety of RCEOP90 containing high-dose epirubicin and RCEOP75 containing standard epirubicin in newly diagnosed young patients with medium/high-risk diffuse large B-cell lymphoma. Half of the participants receive RCEOP regimen containing 90mg/m2 epirubicin, while the other half of participants receive RCEOP …

b-cell lymphoma
platelet count
rituximab
Northern Jiangsu People's Hospital
 (2.0 away) Contact site
  • 38 views
  • 08 Nov, 2020
  • +5 other locations
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

The purpose of this study is to evaluate the efficacy and safety of Tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic ESCC.

capecitabine
squamous cell carcinoma
carcinoma
oxaliplatin
fluorouracil
Subei People's Hospital
 (2.0 away) Contact site
  • 24 views
  • 23 Sep, 2020
  • +204 other locations
Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by Annualized rate of acute moderate and severe COPD exacerbation (AECOPD) Secondary Objectives: To evaluate the effect of dupilumab administered every 2 weeks on Pre-bronchodilator forced …

corticosteroids
bronchodilator
antibiotics
cough
pulmonary function test
Investigational Site Number 1560011
 (2.0 away) Contact site
  • 1142 views
  • 25 Nov, 2020
  • +441 other locations
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

The primary objective of this trial is to assess the effects of ticagrelor plus aspirin versus clopidogrel plus aspirin on reducing the 3-month risk of any stroke (both ischemic and hemorrhagic, primary outcome) when initiated within 24 hours of symptom onset in CYP2Y19 LOF alleles carriers with TIA or minor …

ticagrelor
clopidogrel
aspirin
stroke
ischemic stroke
Affiliated Hospital of Yangzhou University
 (0.4 away) Contact site
  • 0 views
  • 30 Jul, 2020
  • +205 other locations
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation

The purpose of this study is to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated AML who are refractory to or have relapsed after first-line AML therapy as shown with overall survival (OS) compared to salvage chemotherapy. In addition, this study will evaluate …

Site CN126
 (0.0 away) Contact site
  • 242 views
  • 26 Oct, 2020
  • +52 other locations